UA112784C2 - Спосіб лікування та/або профілактики нейродегенеративних розладів - Google Patents
Спосіб лікування та/або профілактики нейродегенеративних розладівInfo
- Publication number
- UA112784C2 UA112784C2 UAA201406463A UAA201406463A UA112784C2 UA 112784 C2 UA112784 C2 UA 112784C2 UA A201406463 A UAA201406463 A UA A201406463A UA A201406463 A UAA201406463 A UA A201406463A UA 112784 C2 UA112784 C2 UA 112784C2
- Authority
- UA
- Ukraine
- Prior art keywords
- prevention
- treatment
- petroleum
- neurodegenerative disorders
- extracts
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- 239000003208 petroleum Substances 0.000 abstract 2
- 240000006450 Anamirta cocculus Species 0.000 abstract 1
- 241000723368 Conium Species 0.000 abstract 1
- 241000723367 Conium maculatum Species 0.000 abstract 1
- 101100505672 Podospora anserina grisea gene Proteins 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Винахід належить до лікування та/або профілактики нейродегенеративного розладу або захворювання, а також способу для поліпшення навченості та пам′яті, що передбачають введення композиції, яка містить екстракти Anamirta cocculus (Анамірта кокулюсоподібна), Conium; maculatum (боліголов плямистий), Ambra grisea (сіра амбра) і Petroleum rectificatum (петролеум ректифікатум), де зазначені екстракти вводять у дозуванні щонайменше приблизно 1 мл/кг маси тіла суб'єкта, якого лікують, на день.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11188841.8A EP2591823A1 (en) | 2011-11-11 | 2011-11-11 | Composition for treating or preventing neurodegenerative disorders |
PCT/EP2012/071898 WO2013068330A1 (en) | 2011-11-11 | 2012-11-06 | Composition for treating or preventing neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
UA112784C2 true UA112784C2 (uk) | 2016-10-25 |
Family
ID=47424893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201406463A UA112784C2 (uk) | 2011-11-11 | 2012-06-11 | Спосіб лікування та/або профілактики нейродегенеративних розладів |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP2591823A1 (uk) |
RU (1) | RU2699038C2 (uk) |
UA (1) | UA112784C2 (uk) |
WO (1) | WO2013068330A1 (uk) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2134113C1 (ru) * | 1997-12-29 | 1999-08-10 | Пищук Владимир Яковлевич | Гомеопатическое лекарственное средство седативного действия "возрастон" |
RU2262348C1 (ru) * | 2004-06-17 | 2005-10-20 | Государственный научный центр социальной и судебной психиатрии им. В.П. Сербского | Способ антигомотоксической терапии сосудистых заболеваний головного мозга |
CH701268B1 (de) * | 2008-04-29 | 2012-06-15 | Gunvant Devichand Oswal | Homöopathische Rezeptur. |
ES2814178T3 (es) * | 2009-10-19 | 2021-03-26 | Amicus Therapeutics Inc | Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central |
-
2011
- 2011-11-11 EP EP11188841.8A patent/EP2591823A1/en not_active Withdrawn
-
2012
- 2012-06-11 UA UAA201406463A patent/UA112784C2/uk unknown
- 2012-11-06 WO PCT/EP2012/071898 patent/WO2013068330A1/en active Application Filing
- 2012-11-06 EP EP12805431.9A patent/EP2776131B1/en active Active
- 2012-11-06 RU RU2014117290A patent/RU2699038C2/ru active
Also Published As
Publication number | Publication date |
---|---|
EP2776131B1 (en) | 2024-05-15 |
RU2699038C2 (ru) | 2019-09-03 |
EP2776131C0 (en) | 2024-05-15 |
EP2776131A1 (en) | 2014-09-17 |
RU2014117290A (ru) | 2015-12-20 |
WO2013068330A1 (en) | 2013-05-16 |
EP2591823A1 (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201000603A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ | |
MX2019012818A (es) | Metodos para mejorar la memoria y la cognicion y para el tratamiento de trastornos de la memoria y cognitivos. | |
PH12018550070A1 (en) | Bivalent bromodomain inhibitors and uses thereof | |
AR084373A1 (es) | Composiciones y metodos para la eliminacion de biopeliculas | |
EA201590655A8 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
CO2017001875A2 (es) | Terapia de combinación contra el alzheimer usando anticuerpos anti-n3pglu más un inhibidor bace | |
EA201290860A1 (ru) | Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата | |
EA201200686A1 (ru) | Новые терапевтические подходы для лечения болезни альцгеймера | |
PH12014502584A1 (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
UA113403C2 (xx) | Спосіб підвищення ефективності folr1 терапії раку | |
EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
GB2503852A (en) | Compounds for the treatment of neuropsychiatric disorders | |
EA201370008A1 (ru) | Лечение когнитивных нарушений | |
MX2022000709A (es) | Regimenes de tratamiento con dexmedetomidina no sedante. | |
DE602006006068D1 (de) | Verwendung von botulintoxin zur verbesserung der magenentleerung und/oder behandlung von gerd | |
EA202091020A1 (ru) | Замещенные имидазопиридинамиды и их применение | |
EP2416795A4 (en) | COGNITIVE DECLINE INHIBITORS | |
MX2023007998A (es) | Regimenes de tratamiento con dexmedetomidina. | |
MX2019001958A (es) | Metodos para tratar la enfermedad de crohn con un anticuerpo anti-nkg2d. | |
WO2013173827A3 (en) | Methods and compositions for inhibiting diseases of the central nervous system | |
WO2013039956A3 (en) | Compositions and methods for treating mood disorders | |
AU2016204146A1 (en) | Methods of Increasing Neuronal Differentiation Using Antibodies to Lysophoshatidic Acid | |
MX2021008081A (es) | Tratamiento de la enfermedad de sjogren con proteinas de fusion de nucleasa. | |
MX343366B (es) | Peptidos de nd2 y metodos de tratamiento de enfermedad neurologica. | |
MA39448B1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical |